OptiNose US, Inc. Sustainability Profile
OptiNose US, Inc., a leading player in the biopharmaceutical industry, is headquartered in the United States and focuses on innovative solutions for patients with chronic sinusitis and other nasal conditions. Founded in 2010, the company has made significant strides in developing unique delivery systems that enhance the efficacy of medications, particularly through its proprietary intranasal technology. OptiNose's core products, including the XHANCE® nasal spray, stand out for their ability to deliver medication directly to the nasal passages, improving patient outcomes and adherence. With a commitment to advancing nasal drug delivery, OptiNose has established a strong market position, recognised for its contributions to the treatment of chronic rhinosinusitis. The company continues to expand its operational reach, aiming to transform the landscape of nasal therapeutics.
DitchCarbon Score
How does OptiNose US, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
OptiNose US, Inc.'s score of 25 is lower than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
OptiNose US, Inc.'s reported carbon emissions
OptiNose US, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of OptiNose, Inc., which may influence its climate commitments and reporting practices. While there are no documented reduction targets or climate pledges from OptiNose US, Inc., it is important to note that emissions data may be inherited from its parent company, OptiNose, Inc. However, specific details regarding emissions or reduction initiatives from this parent organisation are not provided. As a subsidiary, OptiNose US, Inc. may align its sustainability efforts with broader corporate strategies, potentially including initiatives from the Carbon Disclosure Project (CDP) at the cascade level of 1. Nevertheless, without explicit data or commitments, the company's current climate impact and future goals remain unspecified. In summary, OptiNose US, Inc. has not disclosed any carbon emissions data or reduction targets, and its climate commitments are not clearly defined at this time.
How Carbon Intensive is OptiNose US, Inc.'s Industry?
How Carbon Intensive is OptiNose US, Inc.'s Location?
OptiNose US, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
OptiNose US, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
